Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 316,000 | 610,000 | 592,000 | 588,000 | 774,000 |
| Marketable Securities | 94,000 | 112,000 | 97,000 | 117,000 | 119,000 |
| Receivables | 254,000 | 261,000 | 240,000 | 246,000 | 225,000 |
| Inventories | 135,000 | 142,000 | 131,000 | 123,000 | 114,000 |
| Other current assets | 467,000 | 95,000 | 34,000 | 48,000 | 27,000 |
| TOTAL | $1,266,000 | $1,220,000 | $1,094,000 | $1,122,000 | $1,259,000 |
| Non-Current Assets | |||||
| PPE Net | 84,000 | 53,000 | 54,000 | 54,000 | 54,000 |
| Investments And Advances | 41,000 | 52,000 | 93,000 | 98,000 | 98,000 |
| Intangibles | 13,000 | 218,000 | 199,000 | 200,000 | 70,000 |
| Other Non-Current Assets | 356,000 | 309,000 | 291,000 | 281,000 | 288,000 |
| TOTAL | $494,000 | $632,000 | $637,000 | $633,000 | $510,000 |
| Total Assets | $1,760,000 | $1,852,000 | $1,731,000 | $1,755,000 | $1,769,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 |
| Accounts payable and accrued liabilities | 204,000 | 714,000 | 689,000 | 657,000 | 617,000 |
| Accrued Expenses | 1,027,000 | N/A | N/A | N/A | N/A |
| Other current liabilities | 40,000 | 509,000 | 266,000 | 368,000 | 382,000 |
| TOTAL | $1,290,000 | $1,239,000 | $972,000 | $1,043,000 | $1,019,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 237,000 | 236,000 | 236,000 | 236,000 | 237,000 |
| Other Non-Current Liabilities | 424,000 | 401,000 | 406,000 | 404,000 | 462,000 |
| TOTAL | $661,000 | $637,000 | $642,000 | $640,000 | $699,000 |
| Total Liabilities | $1,951,000 | $1,876,000 | $1,614,000 | $1,683,000 | $1,718,000 |
| Shareholders' Equity | |||||
| Common Shares | 68,000 | 69,000 | 69,000 | 69,000 | 68,000 |
| Retained earnings | -295,000 | 1,233,000 | 1,363,000 | 1,322,000 | 1,303,000 |
| Other shareholders' equity | -52,000 | -1,337,000 | -1,324,000 | -1,328,000 | -1,328,000 |
| TOTAL | $-191,000 | $-24,000 | $117,000 | $72,000 | $51,000 |
| Total Liabilities And Equity | $1,760,000 | $1,852,000 | $1,731,000 | $1,755,000 | $1,769,000 |